(Total Views: 301)
Posted On: 01/15/2020 3:09:59 PM
Post# of 112
NetworkNewsBreaks – MCTC Holdings Inc. (MCTC) CEO Recaps Management Restructuring, Strategy Adjustment
MCTC Holdings (OTC: MCTC), a cannabinoid science-forward company developing unique hemp-infusion technologies, recently issued a letter to shareholders from CEO Arman Tabatabaei. An article discussing the company reads, “MCTC reorganized its management in May and redirected its budding strategy from hemp cultivation and post-harvest processing segment to the science of hemp extract and cannabinoid biodelivery, avoiding ‘many of the well-publicized issues currently being experienced in the hemp sectors’ while wholeheartedly embracing the underserved market pertaining to how cannabinoids are best utilized by the human body, Tabatabaei states in his letter (http://nnw.fm/E3sJu). . . . ‘In only a few months, through our internal development efforts and through the efforts of our CROs (contract research organizations), we have begun to make an impact within the cannabinoid sciences arena. . . . We think our cutting-edge research and development work in the laboratory is just getting started,’ Tabatabaei adds.”
Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
MCTC Holdings (OTC: MCTC), a cannabinoid science-forward company developing unique hemp-infusion technologies, recently issued a letter to shareholders from CEO Arman Tabatabaei. An article discussing the company reads, “MCTC reorganized its management in May and redirected its budding strategy from hemp cultivation and post-harvest processing segment to the science of hemp extract and cannabinoid biodelivery, avoiding ‘many of the well-publicized issues currently being experienced in the hemp sectors’ while wholeheartedly embracing the underserved market pertaining to how cannabinoids are best utilized by the human body, Tabatabaei states in his letter (http://nnw.fm/E3sJu). . . . ‘In only a few months, through our internal development efforts and through the efforts of our CROs (contract research organizations), we have begun to make an impact within the cannabinoid sciences arena. . . . We think our cutting-edge research and development work in the laboratory is just getting started,’ Tabatabaei adds.”
Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
(0)
(0)
